Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Eubacterium biforme preparation and use thereof

A technology of Eubacterium and preparation, applied in the field of biological medicine, can solve the problem that the curative effect is not very ideal and so on

Active Publication Date: 2013-02-27
QINGDAO EASTSEA PHARMA +1
View PDF3 Cites 67 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The main ingredients of the current microecological preparations include Bifidobacterium, Lactobacillus, Enterococcus, Bacillus licheniformis, Bacillus subtilis, etc. The curative effect of treating related diseases is not very satisfactory

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Eubacterium biforme preparation and use thereof
  • Eubacterium biforme preparation and use thereof
  • Eubacterium biforme preparation and use thereof

Examples

Experimental program
Comparison scheme
Effect test

preparation Embodiment 1

[0039] Preparation of Medicine Example 1 Preparation of Oral Protruding Eubacterium Live Bacteria Powder, Oral Dimorph Bacteria Live Bacteria Powder and Dual Live Bacteria Powder

[0040] 1 Preparation of bacteria powder and identification of strains

[0041] The feces of a healthy baby in Jiaonan City, Shandong Province were collected, and then the feces were placed in a sterilized anaerobic bottle, and nitrogen gas was blown in while fully mixing, and 2 grams of feces were quickly added to 18 mL of sterilized diluent, and nitrogen gas was blown in while fully mixing. Evenly, in the aseptic operating table, carry out 10 -1 、10 -2 、10 -3 、10 -4 、10 -5 、10 -6 、10 -7 Gradient dilution, take 10 -5 、10 -6 、10 -7 Three dilution gradients, spread on the solid medium for the selective single colony isolation of Eubacterium protrudoides or Eubacterium dimorphus, place in an anaerobic tank, culture at 37°C for 48 hours in anaerobic conditions, and select two single colonies wi...

Embodiment 1

[0056] Example 1. Research on the repairing effect of Eubacterium protrudoides and Eubacterium dimorphus on intestinal mucosa

[0057] 1 Materials and methods

[0058] 1.1 Materials

[0059] 1.1.1 drug protruding fungus liquid (10 7 CFU / mL); Amphimorpha bacterial liquid (10 7 CFU / mL); dual live bacteria solution (10 7 CFU / mL); Bifidobacteria liquid (10 7 CFU / mL); dextran sodium sulfate (DSS, 10g / bottle, Sino-American Biotec); Alcian blue (1g / bottle, Sino-American Biotec).

[0060] 1.1.2 Animals 70 male SD rats, weighing 80-100 g, standard grade 2, were purchased from the Experimental Animal Center of China Institute for the Control of Pharmaceutical and Biological Products.

[0061] 1.2 Method

[0062] 1.2.1 Modeling and treatment of intestinal mucosal injury

[0063] There were 70 rats, 10 rats were used as the normal control group, and the other 60 rats were fed with 3% DSS solution (1mL / 100g) to the fasting rats, once a day for 7 days, and the last time the anal inje...

Embodiment 2

[0072] Example 2. Studies on the Regulatory Expression of Immunity and Inflammatory Factors by Eubacterium protrudoides and Eubacterium amphimorpha

[0073] 1 Experimental materials and methods

[0074] 1.1 Experimental animals: male SD rats, 180-220g.

[0075] 1.2 Experimental drug: mesalamine (200mg / mL); protruding fungus liquid (10 7 CFU / mL); Amphimorpha bacterial liquid (10 7 CFU / mL); dual live bacteria solution (10 7 CFU / mL); Bifidobacteria liquid (10 7 CFU / mL). Provided by Qingdao Donghai Pharmaceutical Co., Ltd.

[0076] 1.3 Experimental reagents: Freund's complete adjuvant (sigma), MTT (sigma); concanavalin (ConA) (Sigma); lipopolysaccharide (LPS) (Sigma); MTT (Sigma), purchased from Beijing Shubowei Chemical Industry Instrument Co., Ltd.; 1640 culture medium (Gibco); lyophilized powder of bovine colonic mucosal protein (self-made); IL-8 ELISA kit (BD); TNF-α ELISA kit (Ebioscience); rat IgG reference serum; Mouse IgG antiserum was purchased.

[0077] 2 Experim...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Average ageaaaaaaaaaa
Login to View More

Abstract

The invention relates to a eubacterium biforme preparation. The eubacterium biforme preparation is a microecological preparation adopting eubacterium biforme as a main active ingredient. The invention also relates to a use of the eubacterium biforme preparation in treatment on related diseases. The eubacterium biforme preparation can be prepared into a drug composition, a health care product, a drink, a veterinary drug and a feed additive.

Description

[0001] This application is a divisional application, the original application date: May 28, 2008, the original application number: 200810108889.X, the original invention creation name: Eubacterium protrudoides and Eubacterium dimorpha preparations and their applications. technical field [0002] The present invention relates to preparations of Eubacterium trachees and Eubacterium dimorphus and their application, in particular to the preparation of Eubacterium trachees and Eubacteria dimorphus alone or in combination as the main active ingredients to make a microecological preparation, and the use of the microecological preparation in the treatment of related diseases The application in the invention belongs to the field of biopharmaceuticals. Background technique [0003] At present, the harm of the misuse of antibacterial drugs in clinical and aquaculture has attracted attention. Since probiotics have no side effects, the use of probiotics to treat related diseases, health c...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K35/74A23L1/29A23K1/16A61P1/04A61P1/10A61P1/12A61P1/14A61P1/16A61P3/06A61P9/00A61P9/10A61P9/12A61P11/00A61P17/00A61P31/14A61P35/00A61P37/04A61P37/08A23L33/00A61K35/741
Inventor 崔云龙李洪福王发合
Owner QINGDAO EASTSEA PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com